LY4515100
/ Eli Lilly
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 30, 2026
A Study of LY4515100 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=123 | Recruiting | Sponsor: Eli Lilly and Company | N=40 ➔ 123 | Trial completion date: Jul 2026 ➔ Mar 2027 | Trial primary completion date: Jul 2026 ➔ Mar 2027
Enrollment change • Trial completion date • Trial primary completion date
May 02, 2026
A Study of LY4515100 in Participants With Pain Following Third Molar Removal
(clinicaltrials.gov)
- P2 | N=212 | Recruiting | Sponsor: Eli Lilly and Company | Not yet recruiting ➔ Recruiting
Enrollment open • Pain
April 07, 2026
A Study of LY4515100 in Participants With Pain Following Third Molar Removal
(clinicaltrials.gov)
- P2 | N=212 | Not yet recruiting | Sponsor: Eli Lilly and Company
New P2 trial • Pain
1 to 3
Of
3
Go to page
1